Chiesi to Buy Amryt for $1.5 Billion in Rare Disease Expansion
Cary, NC, January 8, 2023 (Bloomberg) -- Chiesi Farmaceutici SpA agreed to buy Amryt Pharma Plc for as much as $1.48 billion to expand its portfolio of medicines that treat rare diseases.
Read full article here.
Comments